LEP and metabolic dysfunction-associated steatotic liver disease: Along with cirrhotic complications, another small study including prospectively 94 NAFLD non-cirrhotic patients, showed the occurrence of PVT in 8% of the cohort even without advance liver disease, especially in obese subjects and those with increased leptin levels9.